Related references
Note: Only part of the references are listed.Biomedical applications of yeast- a patent view, part one: yeasts as workhorses for the production of therapeutics and vaccines
Farzin Roohvand et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
Complete genome sequence and comparative genomics of the probiotic yeast Saccharomyces boulardii
Indu Khatri et al.
SCIENTIFIC REPORTS (2017)
Prospective randomized controlled study on the effects of &ITSaccharomyces boulardii&IT CNCM I-745 and amoxicillin-clavulanate or the combination on the gut microbiota of healthy volunteers
Toufic A. Kabbani et al.
GUT MICROBES (2017)
Metabolic Engineering of Probiotic Saccharomyces boulardii
Jing-Jing Liu et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2016)
Characterization of the Probiotic Yeast Saccharomyces boulardii in the Healthy Mucosal Immune System
Lauren E. Hudson et al.
PLOS ONE (2016)
Orally Administrated Whole Yeast Vaccine Against Porcine Epidemic Diarrhea Virus Induced High Levels of IgA Response in Mice and Piglets
Xinglong Wang et al.
VIRAL IMMUNOLOGY (2016)
Transformation of Probiotic Yeast and Their Recovery from Gastrointestinal Immune Tissues Following Oral Gavage in Mice
Lauren E. Hudson et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2016)
Influence of Saccharomyces boulardii CNCM I-745 on the gut-associated immune system
Heike Stier et al.
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2016)
Establishment and application of target gene disruption system in Saccharomyces boulardii
Longjiang Wang et al.
BIOTECHNOLOGY AND BIOPROCESS ENGINEERING (2015)
CasEMBLR: Cas9-Facilitated Multiloci Genomic Integration of in Vivo Assembled DNA Parts in Saccharomyces cerevisiae
Tadas Jakociunas et al.
ACS SYNTHETIC BIOLOGY (2015)
Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis - a review
Margret I. More et al.
CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2015)
Production of Recombinant Human Growth Hormone Conjugated with a Transcytotic Peptide in Pichia pastoris for Effective Oral Protein Delivery
Jun-Yeong Lee et al.
MOLECULAR BIOTECHNOLOGY (2015)
Construction of a Quadruple Auxotrophic Mutant of an Industrial Polyploid Saccharomyces cerevisiae Strain by Using RNA-Guided Cas9 Nuclease
Guo-Chang Zhang et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2014)
Functional Heterologous Protein Expression by Genetically Engineered Probiotic Yeast Saccharomyces boulardii
Lauren E. Hudson et al.
PLOS ONE (2014)
Claudins in intestines Distribution and functional significance in health and diseases
Zhe Lu et al.
TISSUE BARRIERS (2013)
Proof of concept for claudin-targeted drug development
Hidehiko Suzuki et al.
BARRIERS AND CHANNELS FORMED BY TIGHT JUNCTION PROTEINS II (2012)
Vaccines against mucosal infections
Jan Holmgren et al.
CURRENT OPINION IN IMMUNOLOGY (2012)
Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders
Theodoros Kelesidis et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2012)
Mucosal vaccination using claudin-4-targeting
Hideki Kakutani et al.
BIOMATERIALS (2010)
An improved yeast transformation method for the generation of very large human antibody libraries
Lorenzo Benatuil et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2010)
Systematic review and meta-analysis of Saccharomyces boulardii in adult patients
Lynne V. McFarland
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Characterization of different promoters for designing a new expression vector in Saccharomyces cerevisiae
Siavash Partow et al.
YEAST (2010)
Identification of a peptide sequence that improves transport of macromolecules across the intestinal mucosal barrier targeting goblet cells
Sang Kee Kang et al.
JOURNAL OF BIOTECHNOLOGY (2008)
Structure of the claudin-binding domain of Clostridium perfringens enterotoxin
Christina M. Van Itallie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Enhancement of protective immune responses by oral vaccination with Saccharomyces cerevisiae expressing recombinant Actinobacillus pleuropneumoniae ApxIA or ApxIIA in mice
Sung Jae Shin et al.
JOURNAL OF VETERINARY SCIENCE (2007)
Yeast as probiotics - Saccharomyces boulardii
D. Czerucka et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiaev
Laura Edwards-Ingram et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2007)
Enhanced histopathology of mucosa-associated lymphoid tissue
Susan A. Elmore
TOXICOLOGIC PATHOLOGY (2006)
Measurement of faecal immunoglobulin a levels in young children
C Dion et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2004)
Characteristics of claudin expression in follicle-associated epithelium of Peyer's patches: Preferential localization of claudin-4 at the apex of the dome region
H Tamagawa et al.
LABORATORY INVESTIGATION (2003)
Utilization of prebiotic carbohydrates by yeasts of therapeutic relevance
G Mitterdorfer et al.
LETTERS IN APPLIED MICROBIOLOGY (2001)
Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice
A Qamar et al.
INFECTION AND IMMUNITY (2001)
Mucosal immune network in the gut for the control of infectious diseases
H Iijima et al.
REVIEWS IN MEDICAL VIROLOGY (2001)
Saccharomyces boulardii stimulates slgA production and the phagocytic system of gnotobiotic mice
ACP Rodrigues et al.
JOURNAL OF APPLIED MICROBIOLOGY (2000)
Share Paper
